结合全距骨假体的全踝关节置换术:与标准全踝关节置换术的对比研究
本研究对比了10例采用结合定制氧化铝陶瓷全距骨假体的全踝关节置换术(combined TAA)与12例标准全踝关节置换术患者的临床结果。术后combined TAA组JSSF踝-后足评分平均89分(sd 6.1),显著高于标准TAA组的72分(sd 15)(p=0.0034);两组术后AOS和SAFE-Q评分无显著差异。作者结论认为combined TAA的临床结果优于标准TAA。
要点
- combined TAA组术后JSSF评分平均89分(sd 6.1),标准TAA组72分(sd 15),组间差异显著(p=0.0034)。
- 两组术后AOS疼痛与功能评分及SAFE-Q各维度评分均无显著差异。
- combined TAA将TNK踝的胫骨组件与个体化CT设计的氧化铝陶瓷人工距骨结合使用。
核心结论
- 作者结论认为,结合全距骨假体的全踝关节置换术(combined TAA)的临床结果优于标准全踝关节置换术。
研究设计与样本
- 研究纳入2009年至2013年间接受combined TAA的10例患者(2男8女;10踝),按年龄、性别和随访时长与12例接受标准TAA的患者(1男11女;12踝)进行匹配。
- combined TAA采用TNK踝(Kyocera,京都,日本)的胫骨组件和基于个体化CT数据设计的氧化铝陶瓷人工距骨(Kyocera)。
- combined TAA组手术时平均年龄71岁(61至82),标准TAA组75岁(62至82);平均随访分别为58个月(43至81)和64个月(48至88)。
- 结局采用日本足外科学会(JSSF)踝-后足量表、踝骨关节炎量表(AOS)和自填足部评估问卷(SAFE-Q)评估。
主要发现
- combined TAA组术前JSSF评分平均44分(sd 11),标准TAA组49分(sd 10);术后JSSF评分分别为89分(sd 6.1)和72分(sd 15),combined TAA组显著更高(p=0.0034)。
- combined TAA组与标准TAA组术前AOS疼痛评分分别为5.8(sd 3.3)和5.5(sd 3.1),术前AOS功能评分分别为8.6(sd 1.3)和7.1(sd 2.9)。
- combined TAA组与标准TAA组术后AOS疼痛评分分别为2.5(sd 2.5)和2.2(sd 1.9),术后AOS功能评分分别为2.5(sd 3.3)和3.4(sd 2.9),两组术后AOS评分无显著差异。
- combined TAA组与标准TAA组术后SAFE-Q评分分别为:疼痛76(sd 23)对70(sd 23)、身体功能66(sd 25)对55(sd 27)、社会功能73(sd 35)对62(sd 34)、鞋相关73(sd 19)对65(sd 26)、总体健康78(sd 28)对67(sd 29),两组术后SAFE-Q评分无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Total ankle arthroplasty (TAA) has become the most reliable surgical solution for patients with end-stage arthritis of the ankle. Aseptic loosening of the talar component is the most common complication. A custom-made artificial talus can be used as the talar component in a combined TAA for patients with poor bone stock of the talus. The purpose of this study was to investigate the functional and clinical outcomes of combined TAA. PATIENTS AND METHODS: Ten patients (two men, eight women; ten ankles) treated using a combined TAA between 2009 and 2013 were matched for age, gender, and length of follow-up with 12 patients (one man, 11 women; 12 ankles) who underwent a standard TAA. All had end-stage arthritis of the ankle. The combined TAA features a tibial component of the TNK ankle (Kyocera, Kyoto, Japan) and an alumina ceramic artificial talus (Kyocera), designed using individualized CT data. The mean age at the time of surgery in the combined TAA and standard TAA groups was 71 years (61 to 82) and 75 years (62 to 82), respectively. The mean follow-up was 58 months (43 to 81) and 64 months (48 to 88), respectively. The outcome was assessed using the Japanese Society for Surgery of the Foot (JSSF) ankle-hindfoot scale, the Ankle Osteoarthritis Scale (AOS), and the Self-Administered Foot Evaluation Questionnaire (SAFE-Q). RESULTS: The mean preoperative JSSF score of the combined TAA and standard TAA groups was 44 (sd 11) and 49 (sd 10), respectively. The mean postoperative JSSF scores were 89 (sd 6.1) and 72 (sd 15), respectively. The mean postoperative JSSF score of the combined TAA group was significantly higher (p = 0.0034). The mean preoperative AOS scores for pain and function in the combined TAA and standard TAA groups were 5.8 (sd 3.3) and 5.5 (sd 3.1), and 8.6 (sd 1.3), and 7.1 (sd 2.9), respectively. The mean postoperative AOS scores of pain and function were 2.5 (sd 2.5) and 2.2 (sd 1.9), and 2.5 (sd 3.3) and 3.4 (sd 2.9), respectively. There were no significant differences between the two groups in terms of postoperative AOS scores. The mean postoperative SAFE-Q scores were: for pain, 76 (sd 23) and 70 (sd 23); for physical function, 66 (sd 25) and 55 (sd 27); for social function, 73 (sd 35) and 62 (sd 34); for shoe-related, 73 (sd 19) and 65 (sd 26); and for general health, 78 (sd 28) and 67 (sd 29), respectively. There were no significant differences between the two groups in terms of postoperative SAFE-Q scores. CONCLUSION: Combined TAA resulted in better clinical results than standard TAA. Cite this article: Bone Joint J 2019;101-B:443-446.
引用
- Kurokawa H, Taniguchi A, Morita S, et al. Total ankle arthroplasty incorporating a total talar prosthesis: a comparative study against the standard total ankle arthroplasty. Bone Joint J. 2019. PMID: 30929487. doi:10.1302/0301-620X.101B4.BJJ-2018-0812.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。